VITA 34 AG | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,343.00
1,697.00
1,587.00
687.00
153.00
Depreciation, Depletion & Amortization
1,189.00
1,085.00
2,282.00
1,514.00
1,707.00
Other Funds
193.00
271.00
-
-
-
Funds from Operations
2,448.00
2,466.00
417.00
1,528.00
1,104.00
Changes in Working Capital
652.00
1,395.00
2,266.00
818.00
478.00
Net Operating Cash Flow
1,796.00
1,071.00
2,683.00
2,346.00
1,582.00
Capital Expenditures
757.00
440.00
626.00
454.00
753.00
Sale of Fixed Assets & Businesses
2.00
-
-
-
8.00
Purchase/Sale of Investments
-
-
-
125.00
-
Net Investing Cash Flow
777.00
440.00
4,749.00
625.00
13,185.00
Cash Dividends Paid - Total
-
-
442.00
474.00
474.00
Issuance/Reduction of Debt, Net
1,790.00
99.00
860.00
517.00
6,704.00
Net Financing Cash Flow
1,597.00
172.00
418.00
991.00
12,971.00
Net Change in Cash
578.00
803.00
1,648.00
730.00
1,368.00
Free Cash Flow
1,298.00
908.00
2,157.00
1,949.00
904.00
Net Assets from Acquisitions
22.00
-
1,089.00
46.00
12,440.00
Change in Capital Stock
-
-
-
-
6,741.00
Other Uses
-
-
3,034.00
-
-

About VITA 34

View Profile
Address
Deutscher Platz 5a
Leipzig Sachsen (Saxony) 04103
Germany
Employees -
Website http://www.vita34.de
Updated 07/08/2019
Vita 34 AG engages in the collection and storage of umbilical cord blood and stem cells. It operates through Stem Cell Banking segment. The Stem Cell Banking segment collects, processes, and stores stem cells from umbilical cord blood and tissue, and develops cell therapy processes.